Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling

Published:2006-05-04 Issue:2 Volume:70 Page:493-500
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Kim Dong-Chan,Choi Se-Young,Kim Sun-Hee,Yun Bong-Sik,Yoo Ick-Dong,Reddy Nanga. Ravi Prakash,Yoon Ho Sup,Kim Kyong-Tai

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference29 articles.

1. Presence of histamine H2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment

2. Studies on Cancer Chemoprevention by Traditional Folk Medicines XXV. Inhibitory Effect of Isoliquiritigenin on Azoxymethane-Induced Murine Colon Aberrant Crypt Focus Formation and Carcinogenesis.

3. Definition and Antagonism of Histamine H2-receptors

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Important Antihistaminic Plants and Their Potential Role in Health;Phytochemical Drug Discovery for Central Nervous System Disorders;2023-06-30

2. Plants with potential anti-ulcerogenic activity and possible mechanism of actions based on their phyto-constitutional profile;Journal of Complementary and Integrative Medicine;2022-02-14

3. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review;RSC Advances;2022

4. Effect of Glabridin on Microvascular Permeability of Plasma Proteins Induced by Carrageenan;Biointerface Research in Applied Chemistry;2021-06-18

5. Perspectives on the Role of Isoliquiritigenin in Cancer;Cancers;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3